These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6465844)

  • 21. Population-specific screening by mutation analysis for diseases frequent in Ashkenazi Jews.
    DeMarchi JM; Caskey CT; Richards CS
    Hum Mutat; 1996; 8(2):116-25. PubMed ID: 8844209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tay-Sachs disease: high gene frequency in a non-Jewish population.
    Kelly TE; Chase GA; Kaback MM; Kumor K; McKusick VA
    Am J Hum Genet; 1975 May; 27(3):287-91. PubMed ID: 803011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different mutations in Ashkenazi Jewish and non-Jewish French Canadians with Tay-Sachs disease.
    Myerowitz R; Hogikyan ND
    Science; 1986 Jun; 232(4758):1646-8. PubMed ID: 3754980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tay-Sachs disease carrier screening: a model for prevention of genetic disease.
    Kaplan F
    Genet Test; 1998; 2(4):271-92. PubMed ID: 10464605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemistry and genetics of Tay-Sachs disease.
    Gravel RA; Triggs-Raine BL; Mahuran DJ
    Can J Neurol Sci; 1991 Aug; 18(3 Suppl):419-23. PubMed ID: 1834320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of enzyme and DNA analysis in a Tay-Sachs disease carrier screening program.
    Yoo HW; Astrin KH; Desnick RJ
    J Korean Med Sci; 1993 Feb; 8(1):84-91. PubMed ID: 8343225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An unusual genotype in an Ashkenazi Jewish patient with Tay-Sachs disease.
    Shore S; Tomczak J; Grebner EE; Myerowitz R
    Hum Mutat; 1992; 1(6):486-90. PubMed ID: 1301958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tay-Sachs disease in non-Jewish infant in Israel].
    Nadim N
    Harefuah; 2012 Jan; 151(1):16-7, 63. PubMed ID: 22670494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid nonradioactive tracer method for detecting carriers of the major Ashkenazi Jewish Tay-Sachs disease mutations.
    Strasberg PM; Clarke JT
    Clin Chem; 1992 Nov; 38(11):2249-55. PubMed ID: 1424119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mutation common in non-Jewish Tay-Sachs disease: frequency and RNA studies.
    Akerman BR; Zielenski J; Triggs-Raine BL; Prence EM; Natowicz MR; Lim-Steele JS; Kaback MM; Mules EH; Thomas GH; Clarke JT
    Hum Mutat; 1992; 1(4):303-9. PubMed ID: 1301938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
    Hussein N; Weng SF; Kai J; Kleijnen J; Qureshi N
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD010849. PubMed ID: 26264938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prenatal Diagnosis of Tay-Sachs Disease.
    Zhang J; Chen H; Kornreich R; Yu C
    Methods Mol Biol; 2019; 1885():233-250. PubMed ID: 30506202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A genetic profile of the South African Ashkenazi Jewish population.
    Lane AB; Dunn DS; Jenkins T
    S Afr Med J; 1985 Dec; 68(13):935-9. PubMed ID: 4081927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GM2 gangliosidoses in Spain: analysis of the HEXA and HEXB genes in 34 Tay-Sachs and 14 Sandhoff patients.
    Gort L; de Olano N; Macías-Vidal J; Coll MA;
    Gene; 2012 Sep; 506(1):25-30. PubMed ID: 22789865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ashkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic disease.
    Brandt-Rauf SI; Raveis VH; Drummond NF; Conte JA; Rothman SM
    Am J Public Health; 2006 Nov; 96(11):1979-88. PubMed ID: 17018815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymerase chain reaction-generated heteroduplexes from Ashkenazi Tay-Sachs carriers with an insertion mutation can be detected on agarose gels.
    Shore S; Myerowitz R
    Am J Hum Genet; 1990 Jul; 47(1):169. PubMed ID: 2349947
    [No Abstract]   [Full Text] [Related]  

  • 37. A gel electrophoretic assay for detecting the insertion defect in Ashkenazi Jewish carriers of Tay-Sachs disease.
    Shore S; Myerowitz R
    Anal Biochem; 1990 Apr; 186(1):179-81. PubMed ID: 2356966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pedigree discriminant analysis of two French Canadian Tay-Sachs families.
    Keats BJ; Elston RC; Andermann E
    Genet Epidemiol; 1987; 4(2):77-85. PubMed ID: 2953646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tay Sachs disease in Australia: reduced disease incidence despite stable carrier frequency in Australian Jews.
    Lew RM; Proos AL; Burnett L; Delatycki M; Bankier A; Fietz MJ
    Med J Aust; 2012 Dec; 197(11):652-4. PubMed ID: 23230938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Pst+ polymorphism in the HEXA gene with an unusual geographic distribution.
    Kaplan F; Kapoor S; Lee D; Fernandes M; Vienozinskis M; Mascisch A; Scriver CR; Lim-Steele J; Kaback M; Zeiger K; Zoossman-Diskin A; Bonne-Tamir B; Landels E; Bobrow M; Hechtman P
    Eur J Hum Genet; 1993; 1(4):301-5. PubMed ID: 8081943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.